Biotech
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 07/22/13 -- Flamel Technologies (NASDAQ: FLML) expects to release certain financial results for the second quarter of 2013 on Monday, July 29, 2013, before the market ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/19/13 -- RepliCel Life Sciences Inc. (the "Company" or "RepliCel") (OTCBB: REPCF)(CNSX: RP) is pleased to announce the closing ...
CARLSBAD, CA: CARLSBAD, CA -- (Marketwired) -- 07/19/13 -- International Stem Cell Corporation (OTCQB: ISCO) () a California-based biotechnology company developing novel stem cell based therapies, announced today ...
SAN FRANCISCO, CA: Currently Enrolling Patients in Phase 3 Sickle Cell Clinical Trial, Phase 2 ALI Clinical Trial Scheduled to Commence by Q1 2014 ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 07/17/13 -- Theratechnologies Inc. (TSX: TH) announced today that the Court of Appeal of Quebec has dismissed Theratechnologies' motion to dismiss the autho ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/16/13 -- Editors' note: Two photos are associated with this press release.Soricimed Biopharma Inc., a private clinical stage company developing novel canc ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 07/16/13 -- has successfully defended the method claims at the core of international patents covering FLT3 internal tandem duplication (FLT3 ITD) mutation testing. ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 07/15/13 -- Lorus Therapeutics Inc. (TSX: LOR) ("Lorus" or the "Company"), a biopharmaceutical company specializing in the discovery, researc ...
SAN DIEGO, CALIFORNIA: SAN DIEGO, CALIFORNIA -- (Marketwired) -- 07/15/13 -- ("Mirati Therapeutics" or the "Company") (TSX: MYG) (NASDAQ: MRTX) today announced that the NASDAQ Capital Market ("NAS ...
HALIFAX, NOVA SCOTIA: NCIC CTG to Sponsor Randomized Trial With Approximately 250 Ovarian Cancer Patients ...
LAVAL, QUEBEC: Enters into Voting Support Agreement with Jaguar Financial ...
AURORA, ONTARIO: AURORA, ONTARIO -- (Marketwired) -- 07/12/13 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP) (the "Company" or "Helix"), a biopharmaceutical company developing drug candidate ...
LONDON and SOUTH SAN FRANCISCO, CA: LONDON and SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 07/12/13 -- GlaxoSmithKline (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the licence application for the use of fluticasone fu ...
TUSTIN, CA: Positive Phase IIb Data in Second-Line NSCLC and FDA Agreement on Pivotal Phase III Trial Design Position Start of Phase III Trial by Calendar Year-End; Bavituximab's Immunotherapeutic Mechanism ...
PORTLAND, ME: PORTLAND, ME -- (Marketwired) -- 07/11/13 -- (NASDAQ: ICCC) today announced that ®, a USDA-approved scours preventative for newborn dairy and beef calves, has been reviewed by the Organic Materials ...
BOSTON, MA: The Asian Giant Has Invested a Staggering $160 Billion on Biomedicine, and Is Poised to Surpass Japan and Emerge the Second-Largest Spender on R&D, as It Sets Ambitious Targets for Drug Developmen ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 07/11/13 -- Theratechnologies Inc. (TSX: TH) today announced that the US Patent and Trademark Office (USPTO) has issued Patent No. 8,481,489 entitled "GH Se ...
LAVAL, QUEBEC: - New data confirms potential novel therapy for diabetic kidney diseases (DKD), chronic kidney diseases (CKD) and pulmonary fibrosis. ...
MONTREAL, QUEBEC and MISSISSAUGA, ONTARIO: MONTREAL, QUEBEC and MISSISSAUGA, ONTARIO -- (Marketwired) -- 07/10/13 -- Paladin Labs Inc. (TSX: PLB), a leading specialty pharmaceutical company, and Nuvo Research Inc. (TSX: NRI), a specialty pha ...
